Isorhamnetin glycoside isolated from Opuntia ficus-indica (L.) MilI induces apoptosis in human colon cancer cells through mitochondrial damage.


Journal

Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 06 12 2018
revised: 18 06 2019
accepted: 01 07 2019
pubmed: 6 7 2019
medline: 10 9 2019
entrez: 6 7 2019
Statut: ppublish

Résumé

This work aimed to evaluate the mechanisms involved in the apoptosis induction of isorhamnetin-3-O-glucosyl-pentoside (IGP) in metastatic human colon cancer cells (HT-29). To achieve this, we assessed phosphatidylserine (PS) exposure, cell membrane disruption, chromatin condensation, cell cycle alterations, mitochondrial damage, ROS production, and caspase-dependence on cell death. Our results showed that IGP induced cell death on HT-29 cells through PS exposure (48%) and membrane permeabilization (30%) as well as nuclear condensation (54%) compared with control cells. Moreover, IGP treatment induced cell cycle arrest in G2/M phase. Bax/Bcl-2 ratio increased and the loss of mitochondrial membrane potential (63%) was observed in IGP-treated cells. Finally, as apoptosis is a caspase-dependent cell death mechanism, we used a pancaspase-inhibitor (Q-VD-OPh) to demonstrate that the cell death induced by IGP was caspase-dependent. Overall these results indicated that IGP induced apoptosis through caspase-dependent mitochondrial damage in HT-29 colon cancer cells.

Identifiants

pubmed: 31276661
pii: S0009-2797(18)31699-5
doi: 10.1016/j.cbi.2019.108734
pii:
doi:

Substances chimiques

Flavonols 0
Glycosides 0
Plant Extracts 0
3-methylquercetin 07X3IB4R4Z
Quercetin 9IKM0I5T1E
isorhamnetin 3-O-glucoside BI252A6EPL
Caspases EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108734

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Marilena Antunes-Ricardo (M)

Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA., Av. Eugenio Garza Sada 2501 Sur, C.P. 64849, Monterrey, N.L., Mexico.

Annia Hernández-Reyes (A)

Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA., Av. Eugenio Garza Sada 2501 Sur, C.P. 64849, Monterrey, N.L., Mexico.

Ashanti C Uscanga-Palomeque (AC)

Universidad Autonoma de Nuevo Leon, Facultad de Ciencias Biológicas, Laboratorio de Immunologia and Virologia, 66455, San Nicolas de los Garza, N.L., Mexico.

Cristina Rodríguez-Padilla (C)

Universidad Autonoma de Nuevo Leon, Facultad de Ciencias Biológicas, Laboratorio de Immunologia and Virologia, 66455, San Nicolas de los Garza, N.L., Mexico.

Ana Carolina Martínez-Torres (AC)

Universidad Autonoma de Nuevo Leon, Facultad de Ciencias Biológicas, Laboratorio de Immunologia and Virologia, 66455, San Nicolas de los Garza, N.L., Mexico. Electronic address: ana.martinezto@uanl.edu.mx.

Janet Alejandra Gutiérrez-Uribe (JA)

Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA., Av. Eugenio Garza Sada 2501 Sur, C.P. 64849, Monterrey, N.L., Mexico; Tecnologico de Monterrey, Campus Puebla, Av. Atlixcáyotl 2301, C.P. 72453, Puebla, Mexico. Electronic address: jagu@tec.mx.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH